May 23, 2024

The effect of anticholinergic drugs on cognition of patients with Parkinson’s disease: a cohort study from the Egyptian population

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Cognitive dysfunction is a non-motor manifestation of Parkinson's disease (PD). We aimed to determine the frequency and patterns of cognitive dysfunction in treated patients with PD and their predictors.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Hamed et al. (Thu,) studied this question.

synapsesocial.com/papers/68e68be8b6db6435876136de https://doi.org/https://doi.org/10.1080/17512433.2024.2359955

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Parkinson's disease: making the diagnosis, selecting drug therapies.1994 · 6 citations
2The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients2011 · 91 citations
3Updating and validation of the socioeconomic status scale for health research in Egypt2012 · 375 citations
4Anticholinergic therapy and dementia in patients with Parkinson's disease1996 · 35 citations
5Cholinergic deficiency and frontal dysfunction in Parkinson's disease1990 · 125 citations

Preguntar a la IA

Me gusta

Guardar